A new EU project, METSY, develops and applies neuroimaging and bioinformatics
tools to study how lipid metabolism is connected to psychotic disorders and
metabolic co-morbidities such as metabolic syndrome and diabetes.
The overall objective is to identify, prioritize and evaluate multi-modal
blood and neuroimaging biomarkers that have diagnostic potential for
prediction and monitoring psychotic disorders and associated metabolic
co-morbidities. The consortium brings together clinicians, researchers and
industry partners in the domains of psychiatry, neuroimaging, metabolic
research, systems biology and bioinformatics.
The 4-year EU-project is coordinated by Research Professor Matej Orešič from
VTT Technical Research Centre of Finland. Total budget for the project is €
5.94 million €, of which the EU’s share is € 4.23 million.
Project partners: VTT Technical Research Centre of Finland, Biomax Informatics
AG (Germany), Servicio Madrileño de Salud (Spain), University of Turku
(Finland), National Institute for Health and Welfare (Finland), Philips
Research (Germany), King’s College London (UK).